VOR BIOPHARMA INC. Common Stock, par value $0.0001 per share Underwriting AgreementUnderwriting Agreement • December 7th, 2022 • Vor Biopharma Inc. • Biological products, (no disgnostic substances)
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 7th, 2022 • Vor Biopharma Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of December 7, 2022, between Vor Biopharma Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
